For this reason, most clinical practice guidelines still recommend histologic assessment for staging of liver fibrosis and for determining treatment candidacy, in particular when hepatitis B virus (HBV) DNA and/or alanine aminotransferase (ALT) levels are near the threshold for starting therapy [8,9,10]. The gene discussed is GPT; the disease is Hepatic fibrosis.